Related Experiment Video
Updated: May 29, 2026

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
A critical role for noncoding 5S rRNA in regulating Mdmx stability
1Institute for Cancer Genetics, College of Physicians and Surgeons, Columbia University, 1130 Saint Nicholas Avenue, New York, NY 10032, USA.
Abstract:
Both p53 and Mdmx are ubiquitinated and degraded by the same E3 ligase Mdm2; interestingly, however, while p53 is rapidly degraded by Mdm2, Mdmx is a stable protein in most cancer cells. Thus, the mechanism by which Mdmx is degraded by Mdm2 needs further elucidation. Here, we identified the noncoding 5S rRNA as a major component of Mdmx-associated complexes from human cells. We show that 5S rRNA acts as a natural inhibitor of Mdmx degradation by Mdm2. RNAi-mediated knockdown of endogenous 5S rRNA, while not affecting p53 levels, significantly induces Mdmx degradation and, subsequently, activates p53-dependent growth arrest. Notably, 5S rRNA binds the RING domain of Mdmx and blocks its ubiquitination by Mdm2, whereas Mdm2-mediated p53 ubiquitination remains intact. These results provide insights into the differential effects on p53 and Mdmx by Mdm2 in vivo and reveal a critical role for noncoding 5S rRNA in modulating the p53-Mdmx axis.
Insights
Noncoding 5S ribosomal RNA (rRNA) inhibits the degradation of Mdmx protein by Mdm2. Knocking down 5S rRNA triggers Mdmx degradation, activating p53-dependent growth arrest in cancer cells.
Area of Science:
- Molecular biology
- Cancer research
- RNA biology
Background:
- The p53 tumor suppressor pathway is crucial for preventing cancer.
- Mdm2 is a key negative regulator of p53, targeting it for degradation.
- Mdmx protein stabilizes p53 but is itself stable in many cancers, posing a therapeutic challenge.
Purpose of the Study:
- To elucidate the mechanism regulating Mdmx protein stability.
- To investigate the role of noncoding RNA in the p53-Mdmx regulatory axis.
- To identify novel therapeutic targets for modulating Mdmx stability in cancer.
Main Methods:
- Affinity purification and mass spectrometry to identify Mdmx-associated proteins.
- RNA interference (RNAi) to knockdown endogenous 5S rRNA.
- Western blotting to assess protein levels and ubiquitination.
- Cellular assays to evaluate growth arrest.
Main Results:
- 5S rRNA was identified as a major component of Mdmx-associated complexes.
- 5S rRNA directly binds to the RING domain of Mdmx, inhibiting its ubiquitination by Mdm2.
- Knockdown of 5S rRNA significantly increased Mdmx degradation and activated p53-dependent growth arrest.
- Mdm2-mediated p53 ubiquitination remained unaffected by 5S rRNA levels.
Conclusions:
- Noncoding 5S rRNA acts as a natural inhibitor of Mdmx degradation by Mdm2.
- 5S rRNA plays a critical role in modulating the stability of the Mdmx protein.
- Targeting 5S rRNA offers a potential strategy to reactivate the p53 pathway in cancer therapy.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
RNA Stability
RNA Stability
Nuclear Export of mRNA
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
